Mucosal antibody induction by otherwise identical replication-competent and replication-incompetent rhesus monkey rotaviruses was compared. Although psoralen-inactivated virus induced diarrhea, the magnitude of the intestinal antibody response was severely attenuated compared with that of replicating rotavirus, as determined by assay of mucosal antibody-secreting cells. Rotavirus that was neutralized by monoclonal antibodies (anti-VP4 and -VP7) prior to inoculation was similarly ineffective at induction of specific antibodies in intestinal secretions. In contrast to genetically inactivated virus, antibody-neutralized virus did not induce diarrhea. In this murine model, viral replication is an important determinant of antibody induction. The diarrhea response is blocked by neutralizing antibodies, but the mechanism of action is not exclusively the inhibition of viral replication.
Mucosal antibody induction by otherwise identical replication-competent and replication-incompetent rhesus monkey rotaviruses was compared. Although psoralen-inactivated virus induced diarrhea, the magnitude of the intestinal antibody response was severely attenuated compared with that of replicating rotavirus, as determined by assay of mucosal antibody-secreting cells. Rotavirus that was neutralized by monoclonal antibodies (anti-VP4 and -VP7) prior to inoculation was similarly ineffective at induction of specific antibodies in intestinal secretions. In contrast to genetically inactivated virus, antibody-neutralized virus did not induce diarrhea. In this murine model, viral replication is an important determinant of antibody induction. The diarrhea response is blocked by neutralizing antibodies, but the mechanism of action is not exclusively the inhibition of viral replication.
Rotavirus is an important cause of severe gastroenteritis. In children <2 years of age, it is the most important cause of severe diarrhea and contributes significantly to infant mortality in less developed countries. This tremendous worldwide impact has led to efforts to develop an effective vaccine.
Rotavirus infection has been studied in animal models using homologous and heterologous strains. Rhesus rotavirus (RRV) inactivated by RNA cross-linking with psoralens and longwave UV lignt, which renders rotavirus transcriptionally inactive but preserves antigenic structures [1] , has been used in studies to assess the role of replication in immunity and disease. Inactivated rotavirus induced diarrhea in murine pups [2] , while intestinal antibody responses to small doses of inactivated RRV was augmented by microencapsulation [3] .
Previous studies have shown that neutralizing monoclonal antibodies (NMAbs) prevented diarrhea in murine models [4, 5] . The mechanism mediating protection was not determined but was presumed to be related to interference with viral replication. These studies used modest doses of virus that do not cause diarrhea when inactivated. No studies of mucosal immune responses to MAb-neutralized rotavirus have been reported. This report compares the effect of antibody-neutralized RRV with psoralen-inactivated RRV on stimulation of intestinal antibody production.
Rotavirus protein capsids are constructed in three layers around the double-stranded RNA genome (reviewed in [6] ). VP6 is the major structural element of the second layer and constitutes ""-' 50% of virion mass, but VP6 antibodies do not inhibit viral replication in culture or protect from disease in passive challenge experiments. VP4 and VP7 constitute the outermost capsid, and antibodies to both mediate viral neutralization in tissue culture and disease protection in challenge models; VP4 also is responsible for cell attachment [7] . Trypsin cleavage of VP4 into 2 fragments (VP5* and VP8*) is associated with viral activation and is required for infectivity.
For these experiments, we used MAbs directed at VP4 and VP7 and nonneutralizing VP6. VP4-specific MAbs were directed at VP8*, a trypsin cleavage product of VP4. The MAbs directed at VP8* and VP7 neutralize by two different mechanisms: VP8* antibodies block attachment to cells, while VP7 MAbs permit cell attachment but block replication [8] .
Materials and Methods
Animals. Pregnant CD2F I mice were obtained from Taconic Farms (Germantown, NY) and housed in microisolator cages containing sterile bedding, food, and water. Sera were tested by focus neutralization assay to ensure no prior exposure to rotavirus.
Virus. RRV was propagated in MA104 cells as previously described [9, 10] and purified by fluorocarbon extraction and sucrose gradient centrifugation. Virus bands were identified by hemagglutination (HA), dialyzed against TRIS-saline-2 mM csci, and reconcentrated by ultracentrifugation. Aliquots were used to prepare psoralen-inactivated virus (PI-RRV) by incubation with 40 ILg/mL AMT (4'-aminomethyl-4,5',8-trimethyl psoralen) on ice under A 365 UV light for 50 min [3] . Double-layered virus (EDTA-RRV) was prepared by incubation of purified virus at 37°C for 30 min in 10 mM EDTA, followed by ultracentrifugation.
PI-RRV was characterized by HA titer (I :6400 to I:2800) and failure to infect MA 104 monolayers in immunohistochemical infectious focus assays. Spectrophotometry at A 260 , A 2 80 , and A 325 provided a basis for comparing inoculations. The standard inoculation dose, containing~10
8 focus-forming units (or the equivalent), was 1.0-1.5 at A 260 and A 28 0 and <0.300 at A 325 • MAbs. The MAbs, 7A12, 159, and 255/60, were previously characterized [10] . Antibody was purified from hybridoma culture supernatants by protein-G gel chromatography. NMAb-virus samples were incubated for 60 min at 37°C with 0.25 mg MAb/mL to ensure excess antibody. The neutralization titers of antibody preparations (except nonneutralizing VP6) were measured in an immunohistochemical neutralization assay and exceeded 1:10,000 (50% focus reduction) [11] ; neutralization of RRV samples was documented prior to inoculation. A small number of infected cells could be seen in monolayers exposed to the 7A12-neutralized virus, but this number did not increase until the antibody was diluted 16-fold beyond that used in the experiment. This "breakthrough" pattern of neutralization exhibited by VP8* antibodies has been noted previously (Shaw RD, Greenberg HB; unpublished observations) and is thought to result from moderate affinity and a less efficient mechanism of neutralization (see Discussion) [8] . EDTAtreated virus lacked HA (titer < 1:2) and failed to produce new viral antigen in immunohistochemical assays. NMAb-PI-RRV samples were treated similarly to infectious RRV and were normalized by HA titer. Obviously, neutralization assays of antibodytreated inactivated virus are not informative except to document that psoralen inactivation was successful.
Immunization. Litters were infected with RRV (ATCC VR 954) at 9-10 days. Pups were restricted from suckling 60 min before and after inoculation. The dose of virus (live or inactivated) used in these experiments caused diarrhea in >95% of pups, usually 1-3 days after infection. Pups were inoculated with 100-JLL aliquots containing 10 7-108 focus-forming equivalents of RRV, PI-RRV, NMAb-RRV, NMAb-PI-RRV, or EDTA-RRV.
Intestinal fluid collection. The contents of the small intestine were collected as previously described [11] . In brief, the small intestine was removed, the outside was rinsed with cold Hanks' balanced salt solution, and 5 mL of cold HBSS was rinsed through the inside of each intestine, collected in a tube, and mixed 1:1 with protease inhibitor solution (50 mM EDTA and 0.1 mg/mL soybean trypsin inhibitor, pH 7.4). The tube was vortex-mixed for 1 min and centrifuged (850 g, 4°C) for 10 min; then 100 JLL of phenylmethylsulfonyl fluoride (PMSF; 100 mM) was added. The tube was centrifuged (1300 g, 4°C) for 25 min, and 100 JLL of PMSF, 0.01% sodium azide, and 300 JLL of fetal bovine serum (FBS) were added to supernatant in a clean tube. Aliquots were frozen at -80°C until used.
Lymphocyte isolation procedure. We used a previously published procedure for harvesting functionally active intestinal lymphoid cells [11] . Cells are released from intestinal tissue with EDTA and collagenase and purified on discontinuous percoll gradients. Viable cells were enumerated by trypan blue dye exclusion.
ELISPOT Immobilon (Millipore, Bedford, MA), a hydrophobic polyvinylidene difluoride membrane, was used as the proteinbinding matrix as previously described [11] . The membrane was coated with gradient-purified RRV in TNC buffer (0.01 M TRIS, 0.01 M NaCI, 2 mM csci, pH 7.5) or with goat anti-mouse IgA in PBS. Lanes were washed and blocked with PBS-5% FBS.
Lymphocyte suspensions were incubated on antigen capture for 2 h at 37°C. Detection of bound mouse immunoglobulin with IgAspecific, biotinylated anti-mouse immunoglobulin (KPL, Gaithersburg, MD) and avidin-horseradish peroxidase (Vector Labs, Burlingame, CA) was done with a precipitating substrate, tetramethyl benzidine (KPL), which resulted in blue spots. Results were expressed as antibody-secreting cells (ASCs)/10 6 mononuclear cells. ELISA. IgA-specific antibodies to rotavirus were measured in intestinal contents with an ELISA, using a modification of a published method [11] . A guinea-pig anti-RRV serum was used as capture antibody on Immulon II (Dynatech, Chantilly, VA) micro- titer plates. Two-fold dilutions of intestinal fluid samples in PBS/ 1% FBS were added and incubated for 2 h. Bound antibodies were detected using biotinylated isotype-specific goat anti-mouse immunoglobulin and avidin-horseradish peroxidase; soluble TMB (KPL) was used as substrate. The reaction was stopped after 10 min with I N H 2S04 , and A 4 S0 was measured. Nonspecific binding was evaluated in wells without RRV, and values were subtracted from RRV wells. The titer was the greatest dilution that exceeded average background by 2 SD.
Results
Mice were inoculated with RRV, PI-RRV, single-shell RRV, NMAb-RRV, NMAb-PI-RRV, or buffer at 9-10 days of age. Controls included psoralen-UV-treated buffer and antibodies alone. Mice were examined twice daily by an observer blinded to the inoculation. Findings were graded as follows: 0 (no stool expressed), 1+ (normal, formed, stool), 2+ (pasty stool), 3 + (some liquid in stool), or 4+ (copious, yellow, liquid stool). Onset of diarrhea was typically 24 h after inoculation, and duration was~48 h. Findings are summarized in tables 1 and 2 as the greatest score assigned during the response period. The members of inoculation groups did not differ by more than one point. Mice inoculated with RRV or PI-RRV and those inoculated with RRV or PI-RRV treated with the VP6 NMAb (255/60) had liquid stools; there was no detectable difference in stools of sham-inoculated mice and those inoculated with VP7 NMAb (159)-treated or the VP4 NMAb (7AI2)-treated RRV or PI-RRV. NOTE. RRV, PI-RRV, and EDTA-treated RRV were single-capsid or double-layered particles produced by loss of VP4 and VP7 after divalent cation chelation.
* Diarrhea scale: 0, no stool on palpation; 1+, normal formed stool; 2+, soft stool; 3+, mostly liquid stool; 4+, copious liquid.
t By ETA. Nos. represent greatest dilution yielding optical density > 2 SD above negative control. n = 3, with each of ErA tests including pooled sera from 2 mice. RRV and RRV + anti-VP6 are significantly different from all others, P < .01.
IntestinalIgA response to rotavirus inoculations. Negative controls showed <50 IgA Rk.V-specific ASC/I0 6 , the minimal detectable level (EDTA-RRV produced <50 as well, data not shown). Hybridoma cells that secreted rotavirus-specific antibodies against VP6, VP7, and VP4 (MAbs 255/60, 4F8, and 7A 12, respectively) were included as positive controls in each experiment and showed comparable numbers of spots in the immunoglobulin and rotavirus-capture lanes. Nonspecific IgAsecreting cells were not significantly different among all groups. RR V-specific ASCs are shown in table 1. Cells were harvested 21-48 days after infection, a period previously identified as a plateau phase of the intestinal antibody response [11] . The response to inactivated PI-RRV (526 ASC/l0 6 mononuclear cells) was in a range reported for nonreplicating intestinal antigens, such as cholera toxin, after repeated oral vaccinations [12] . Measurement of virus-specific serum IgG, a poor correlate of intestinal antibody responses, did not show statistically significant distinctions between the 2 groups of inoculated mice, although both groups exhibited relatively low-level responses, and the trend toward greater responses in mice inoculated with RRV was apparent (ranges: RRV, 1:200-1 :3200; PI-RRV, 1:<50-1 :800).
Using an ELISA, we evaluated the intestinal virus-specific IgA responses to RRV or PI-RRV treated with NMAbs. While other measures of mucosal antibody secretion, such as the ELISPOT or fragment cultures, may yield more quantitative data on mucosal antibody levels, this assay was adequate to distinguish the sharp differences among these samples (table  2) . Replicating virus alone or with nonneutralizing antibodies yielded high titers of virus-specific IgA. Virus impeded by genetic cross-linking (PI-RRV) yielded responses comparable to those of controls, regardless of antibody treatment, as did EDTA-RRV. RRV treated with anti-VP4 or -VP7 MAbs showed marked reductions in virus-specific titers compared with non -antibody-treated counterparts, but the titers were greater than those for controls.
Discussion
A critical role for viral replication as a stimulus of mucosal antibodies has been suggested from work with murine models in which similar viruses or reassortants of differing virulence were studied [13 -15] . The present data show that nonreplieating rotavirus is only "'"' 1/100 as effective in inducing specific IgA as identical replicating rotavirus in a murine model of heterologous infection. A previous study using inactivated rotavirus in a murine model showed that low-dose (1. 75 pg) inactivated RRV failed to elicit antibodies detectable with an organ culture assay [15] , although the authors noted responses with> 10 ug, which is approximately the dose used in the present study. Those findings are consistent with the present study because we found small but detectable levels of virus-specific antibodies in mice inoculated with inactivated virus.
The mechanism of replication-dependent rotavirus immunogenesis is unknown, but speculation may plausibly include several factors. Increased viral antigen load may occur with replication. There are limited and conflicting data quantitatively assessing viral replication in heterologous host models, but some increase in virus load as a result ofreplication is assumed, and the dose-dependence discussed above suggests that antigen load is related to antibody responses. Alternatively, intestinal epithelial cells (or other "professional" antigen-presenting cells, such as dendritic cells in Peyer's patches) may function more efficiently when viral replication occurs within. Active replication may provide other factors that enhance the antibody response, such as cytokines of epithelial origin that promote specific immunoglobulin secretion. We have recently reported, however, that interleukin 8 (lL-8) (a major inflammatory mediator known principally for chemoattractive and cell-activating properties) is released from cultured epithelial cells as well as by inactivated PI-RRV and infectious RRV [9] . Antibody-treated virus (NMAb-RRV and NMAb-PI-RRV) elicited reduced intestinal antibodies, a finding in concert with a reduction in diarrhea. This was accomplished by antibodies specific for VP8 * and VP7, despite differing mechanisms of neutralization. Anti-VP8* antibodies prevent infection by preventing cell attachment. Anti-VP7 antibodies, however, can inhibit previously cell-bound virus. Reduced diarrhea resulting from "neutralizing" VP7 antibody-treatment of inactivated virus may be due to inhibition of cell membrane penetration.
It is not known whether any outer capsid antibody-coated particles enter cells.
We have observed a similar outcome of antibody treatment on RRV-induced IL-8 release from cultured intestinal cells, a process which, as noted above, is induced by both RRV and PI-RRV: antibodies to outer capsid proteins but not VP6 inhibited IL-8 induction by either RRV or PI-RRV [9] . Therefore, effects of antibodies on both diarrhea and epithelial chemokine induction suggest that viral penetration of the epithelial cell membrane (but not replication of new viral antigen) may be required for both processes, and penetration may be inhibited by antibodies directed at the outer capsid proteins but not VP6.
These data indicate that viral antigen replication is an important determinant of mucosal IgA responses. Diarrhea, however, can be induced in the absence of virus antigen replication. A full understanding of the biology of the interaction of rota virus with intestinal epithelial cells may improve prevention and treatment strategies for this and similar infections.
